FDA Advisors Recommend Alcon’s Multifocal Toric IOL
This article was originally published in The Gray Sheet
Executive Summary
The company received a resounding yes from an FDA panel to approve the lens for cataract surgery to treat presbyobia and astigmatisms..
You may also be interested in...
Ophthalmic Panel To Eye Alcon’s AcrySof IQ Restor Multifocal IOL
FDA’s ophthalmic devices advisory panel plans to meet on Nov. 14 to assess Alcon Laboratories’ PMA application for its AcrySof IQ Restor multifocal toric posterior chamber intraocular lens.
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.